Wednesday, December 6, 2017

FDA Approves Zelboraf (vemurafenib) for Erdheim-Chester Disease with BRAF V600 Mutation

›
In continuation of my update on Vemurafenib The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib...
Tuesday, December 5, 2017

FDA Approves Vyzulta (latanoprostene bunod) Ophthalmic Solution for Open-Angle Glaucoma, Ocular Hypertension

›
Valeant Pharmaceuticals International, Inc.'s   announced that the U.S. Food and Drug Administration (FDA) has approved the New Dr...
Monday, December 4, 2017

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

›
In continuation of my update on  5-azacytidine Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel d...

FDA Approves Alecensa (alectinib) as First-Line Treatment for ALK-Positive Metastatic Non-Small Cell Lung Cancer

›
Genentech, a member of the Roche Group  announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Appl...

Drug that stimulates neuron pruning promotes goal-directed behavior in mice

›
A drug that stimulates neuron pruning can nudge mice away from habit-driven behaviors when combined with retraining, neuroscientists have ...
Friday, December 1, 2017

FDA Approves Prevymis (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients

›
Merck & Co., Inc. ,  announced that the U.S. Food and Drug Administration (FDA) has approved Prevymis ( letermovir ) once-daily tab...
Thursday, November 30, 2017

FDA Approves New 10 mg Dosing for Xarelto (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)

›
In continuation of my update on  rivaroxaban Janssen Pharmaceuticals, Inc. announced  the U.S. Food and Drug Administration (FDA) ...

FDA Approves Auryxia (ferric citrate) Tablets as a Treatment for People with Iron Deficiency Anemia and Chronic Kidney Disease, Not on Dialysis

›
Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a company focused on bringing innovative medicines to people with kidney disease, today anno...
Wednesday, November 29, 2017

Allergan Receives FDA Approval for Vraylar (cariprazine) in the Maintenance Treatment of Schizophrenia

›
In continuation of my update on Cariprazine Allergan plc (NYSE: AGN)  announced that the U.S. Food and Drug Administration (FDA) has...
Monday, November 27, 2017

FDA Approves Abilify MyCite (aripiprazole) Pill with Sensor to Digitally Track if Patients Have Ingested Their Medication

›
In continuation of my update on  aripiprazole   The U.S. Food and Drug Administration today approved the first drug in the U.S. with ...
Friday, November 24, 2017

Newly discovered drug-like compound may revolutionize treatment of autoimmune diseases

›
University of Colorado Boulder researchers have discovered a potent, drug-like compound that could someday revolutionize treatment of ...
Thursday, November 23, 2017

Multiple sclerosis drug can beat obstinate bacteria

›
In continuation of my update on  glatiramer Encountering bacteria with innocent names such as  Pseudomonas aeruginosa   and Enterobacter...

Methotrexate drug holiday improves flu vaccine efficacy in rheumatoid arthritis patients

›
In continuation of my update on methotrexate People with RA who stop taking methotrexate treatment for just two weeks after they ha...
Wednesday, November 22, 2017

FDA Approves Juluca, First Two-Drug Regimen for HIV Patients

›
In continuation of my updates on  dolutegravir and rilpivirine , The FDA has approved the first complete treatment regimen containing o...

New findings on tolvaptan as autosomal dominant polycystic kidney disease treatment

›
 In continuation of my update on tolvaptan A phase 3 trial studying the effects of tolvaptan has found that the drug slowed the ...